BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10783335)

  • 1. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions: further insights into the role for oxidative stress in Fanconi's anaemia phenotype.
    Pagano G
    Carcinogenesis; 2000 May; 21(5):1067-8. PubMed ID: 10783335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
    Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
    Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-modulated xenobiotic action and ROS formation: a mirror or a window?
    Pagano G
    Hum Exp Toxicol; 2002 Feb; 21(2):77-81. PubMed ID: 12102500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for nutritional interventions in the clinical management of Fanconi anemia.
    Pagano G; Korkina LG
    Cancer Causes Control; 2000 Dec; 11(10):881-9. PubMed ID: 11142522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi anaemia proteins: major roles in cell protection against oxidative damage.
    Pagano G; Youssoufian H
    Bioessays; 2003 Jun; 25(6):589-95. PubMed ID: 12766948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress of research on protein composition and gene therapy of Fanconi anaemia - review].
    Li ZY; Zou YF; Deng YB
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):231-5. PubMed ID: 15157341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking.
    Clarke AA; Philpott NJ; Gordon-Smith EC; Rutherford TR
    Br J Haematol; 1997 Feb; 96(2):240-7. PubMed ID: 9029006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality.
    Pang Q; Christianson TA; Keeble W; Diaz J; Faulkner GR; Reifsteck C; Olson S; Bagby GC
    Blood; 2001 Sep; 98(5):1392-401. PubMed ID: 11520787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of immortalized fibroblastoid cell lines from an FA(C) mouse model.
    Tomkins DJ; Care M; Carreau M; Buchwald M
    Mutat Res; 1998 Jul; 408(1):27-35. PubMed ID: 9678061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fanconi's anemia--chromosome breakage studies in homozygotes and heterozygotes.
    Rosendorff J; Bernstein R
    Cancer Genet Cytogenet; 1988 Jul; 33(2):175-83. PubMed ID: 3133104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation.
    Guillouf C; Vit JP; Rosselli F
    Biochimie; 2000 Jan; 82(1):51-8. PubMed ID: 10717387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic correction of Fanconi anemia group C knockout mice.
    Gush KA; Fu KL; Grompe M; Walsh CE
    Blood; 2000 Jan; 95(2):700-4. PubMed ID: 10627482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fanconi's anemia cell lines show distinct mechanisms of cell death in response to mitomycin C or agonistic anti-Fas antibodies.
    Clarke AA; Gibson FM; Scott J; Myatt N; Rutherford TR
    Haematologica; 2004 Jan; 89(1):11-20. PubMed ID: 14754601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
    de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H
    Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein.
    Pichierri P; Averbeck D; Rosselli F
    Hum Mol Genet; 2002 Oct; 11(21):2531-46. PubMed ID: 12354779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector.
    Walsh CE; Nienhuis AW; Samulski RJ; Brown MG; Miller JL; Young NS; Liu JM
    J Clin Invest; 1994 Oct; 94(4):1440-8. PubMed ID: 7929819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knock-out mouse cells.
    Otsuki T; Wang J; Demuth I; Digweed M; Liu JM
    Int J Hematol; 1998 Apr; 67(3):243-8. PubMed ID: 9650445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.